GEHC: Leadership change

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 13, 2026, the Board of Directors (the “Board”) of GE HealthCare Technologies Inc. (“GE HealthCare”) appointed William K. Grogan as Chief Financial Officer, effective September 14, 2026. George A. Newcomb, who currently serves as GE HealthCare’s interim Chief Financial Officer, will cease serving in that interim role on September 14, 2026, and will continue serving as GE HealthCare’s Controller and Chief Accounting Officer. Mr. Grogan, age 48, has served as Executive Vice President and Chief Financial Officer of Xylem Inc., a global water solutions company, since October 2023. Previously, Mr. Grogan served as Senior Vice President and Chief Financial Officer of IDEX Corporation, a global engineered products company, from January 2017 until September 2023. On August 13, 2026, the Talent, Culture, and Compensation Committee (the “Committee”) of the Board approved Mr. Grogan’s compensation after considering a variety of factors, including Mr. Grogan’s experience and skills, data and advice from its independent compensation consultant, the compensation Mr. Grogan will forfeit at his current employer, and GE HealthCare’s Total Rewards Philosophy. Mr. Grogan’s offer letter provides for an annual base salary of $900,000, target annual bonus opportunity equal to 100% of base salary, an annual long-term incentive (“LTI”) award with a target grant date value of $3,300,000, and participation in GE HealthCare’s benefit plans, including its Retirement Savings Plan, Restoration Plan, and US Severance and Change in Control Plan for CEO and Leadership Team (the “Severance Plan”). In consideration of the 2026 annual bonus h